Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adenocarcinoma × iron isomaltoside 1000 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Classical hematology 1

Conditions

Stomach Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Anemia, Iron-Deficiency 1 Anemia 1 Adenocarcinoma 1

Interventions

ferric carboxymaltose 2 Pemetrexed 2 Drug Therapy 2 iron isomaltoside 1000 1 icotinib 1 ferrous sulfate 1 elemene 1 aumolertinib 1 aflutinib 1 Rabeprazole 1 Gemcitabine 1 Docetaxel 1 Desflurane 1 Carboplatin 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01927328 2016-10-28

IRON

Nottingham University Hospitals NHS Trust

Phase 4 Unknown

Classical hematologyGastrointestinal

Adenocarcinoma, Anemia, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡